Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]

The summary for the Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]: This Funding Opportunity Announcement (FOA) issued by The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the Fogarty International Center (FIC), and the National Institute of Allergy and Infectious Diseases (NIAID), encourages applications from eligible domestic and foreign institutions that propose to build capacity in their research administration infrastructures. The Biomedical Biobehavioral Research Administration Capacity Development (BRAD) Program (G11) promotes the establishment of rigorous and externally supported biomedical and biobehavioral research and/or research-related training programs by providing support for strengthening institutional research administration infrastructures.
Federal Grant Title: Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]
Federal Agency Name: National Institutes of Health
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-11-270
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: Child Health and Human Development Extramural Research
Current Application Deadline: Jul 31, 2013
Original Application Deadline: Jul 31, 2013
Posted Date: Jul 21, 2011
Creation Date: Jul 21, 2011
Archive Date: Aug 31, 2013
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) ; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical T...
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Wo...
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Wo...
Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible I...
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical T...
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical...
Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com